CARDIOTOXICITY

This study looks at whether different levels of exercise can help the hearts of young adults who survived childhood cancer and were treated with a type of chemotherapy called anthracyclines. Twenty survivors between ages 18 and 39 will take part. The goal is to see if exercise ca…

This study follows 200 men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy) for at least 6 months. Researchers want to understand how this treatment affects the heart, including changes in heart function and the risk of heart failure. They wil…

This study tests if a wearable sensor can accurately estimate the heart's pumping ability (LVEF) in 50 adults who are already scheduled for an echocardiogram. The goal is to see if the sensor matches the standard ultrasound test. If successful, this could lead to easier, more fre…

This study looks at how well a cardiopulmonary exercise test (CPET) can measure oxygen use in women with HER2-positive breast cancer who have mild heart problems from their cancer treatment. The goal is to see if this test can help predict how their heart and lungs will handle co…

This study looks at how immune checkpoint inhibitors, a type of cancer drug, affect the tiny blood vessels in the heart. Researchers will use heart scans and blood tests to check for changes in 25 people with breast or lung cancer. The goal is to learn more about potential heart …

This study follows 221 people with stage II or III lung cancer to see how chemoradiation therapy affects the heart over two years. Participants undergo heart scans, blood tests, and surveys before, during, and after treatment. The goal is to better understand and detect heart dam…

This study follows 50 people with chronic lymphocytic leukemia who are starting treatment with acalabrutinib or zanabrutinib. Participants use wearable devices at home to monitor their heart rhythm and blood pressure. The goal is to learn how often these drugs cause high blood pr…

This study follows 200 women with breast cancer who are receiving chemotherapy drugs doxorubicin or trastuzumab. Researchers want to understand how these treatments affect the heart over time and how factors like race, income, and access to healthcare play a role. Participants wi…